BRIEF published on 03/17/2026 at 07:35, 1 month 23 days ago Oeneo launches a €21 million share buyback program Share Buyback Treasury Oeneo Caspar SAS Accelerating Effect
BRIEF published on 03/17/2026 at 07:10, 1 month 23 days ago Sequential Secures $3.5M for AI-Driven Skin Health Platform AI-powered Platform Funding Round Biomarker Discovery Sequential Skin Health Innovation
BRIEF published on 03/17/2026 at 07:10, 1 month 23 days ago Sequential lève 3,5 millions de dollars pour sa plateforme de santé cutanée basée sur l'IA Plateforme Alimentée Par L'IA Découverte De Biomarqueurs Tour De Financement Séquentiel Innovation En Matière De Santé De La Peau
BRIEF published on 03/17/2026 at 07:08, 1 month 23 days ago Sartorius Stedim Biotech Sets New Growth Targets with Biopharma Focus Advanced Therapies Market Expansion Growth Targets Biopharma Strategy Bioprocessing Technologies
BRIEF published on 03/17/2026 at 07:08, 1 month 23 days ago Sartorius Stedim Biotech se fixe de nouveaux objectifs de croissance axés sur le secteur biopharmaceutique. Objectifs De Croissance Thérapies Avancées Expansion Du Marché Stratégie Biopharmaceutique Technologies De Bioprocédés
BRIEF published on 03/17/2026 at 07:08, 1 month 23 days ago Sartorius Stedim Biotech affine sa stratégie et vise une croissance ambitieuse EBITDA Sartorius Stedim Biotech Objectifs De Croissance Stratégie Biopharmaceutique Portefeuille Produits
BRIEF published on 03/17/2026 at 07:08, 1 month 23 days ago Sartorius Stedim Biotech refines its strategy and aims for ambitious growth EBITDA Sartorius Stedim Biotech Product Portfolio Growth Objectives Biopharmaceutical Strategy
BRIEF published on 03/17/2026 at 07:05, 1 month 23 days ago PolyPeptide Announces 2026 Annual General Meeting Annual General Meeting Financial Statements Board Re-election PolyPeptide Group Compensation Approval
BRIEF published on 03/17/2026 at 07:05, 1 month 23 days ago PolyPeptide annonce sa réunion générale annuelle de 2026 États Financiers Assemblée Générale Annuelle Réélection Du Conseil D'administration Groupe Polypeptide Approbation De La Rémunération
BRIEF published on 03/17/2026 at 07:05, 1 month 23 days ago Springer Nature Reports Strong 2025 Growth, Optimistic for 2026 Financial Results Revenue Increase Business Growth Open Access Research Segment
Published on 05/09/2026 at 01:30, 9 hours 3 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 10 hours 33 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 13 hours 55 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 15 hours 20 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 15 hours 31 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 15 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 15 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 15 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
